U.S. Markets closed

Genus plc (GNS.L)


LSE - LSE Delayed Price. Currency in GBp
Add to watchlist
1,861.00+6.00 (+0.32%)
At close: 5:02PM BST

Genus plc

Matrix House
Basing View
Basingstoke RG21 4DZ
United Kingdom
44 1256 347 100
http://www.genusplc.com

SectorHealthcare
IndustryBiotechnology
Full Time Employees2,501

Key Executives

NameTitlePayExercisedAge
Mr. Karim BitarChief Exec. Officer and Exec. Director1.22MN/A52
Mr. Stephen WilsonGroup Fin. Director and Exec. Director788kN/A57
Dr. Jonathan Lightner Ph.D.Chief R&D and Scientific OfficerN/AN/AN/A
Mr. Dan HartleyGroup Gen. Counsel and Company Sec.N/AN/AN/A
Ms. Catherine GlickmanGroup HR DirectorN/AN/AN/A
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in GBp.

Description

Genus plc, together with its subsidiaries, engages in the application of quantitative genetics and biotechnology to animal breeding in the porcine, dairy, and beef sectors. It operates through four segments: Genus PIC, Genus ABS, Genus Asia, and Research and Development. The company sells breeding pigs under the PIC name; and bull semen to the dairy and beef markets under the ABS name. It offers boars and sows, as well as embryos. The company sells its products to farmers and food producers in North America, Latin America, Europe, the Middle East, Africa, and Asia. Genus plc was incorporated in 1994 and is headquartered in Basingstoke, the United Kingdom.

Corporate Governance

Genus plc’s ISS Governance QualityScore as of May 1, 2017 is 4. The pillar scores are Audit: 1; Board: 7; Shareholder Rights: 1; Compensation: 4.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.